We are live on ! Find out more
TVTX icon

Travere Therapeutics
TVTX

124 hedge funds and large institutions have $643M invested in Travere Therapeutics in 2020 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 49 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $611M → $643M (+$31.6M)

1.98% more ownership

Funds ownership: 100.14% → 102.12% (+2%)

5% less funds holding

Funds holding: 131 → 124 (-7)

23% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 26

35% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 49

63% less call options, than puts

Call options by funds: $1.67M | Put options by funds: $4.51M

Holders
124
Holders Change
-7
Holders Change %
-5.34%
% of All Funds
2.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
32
Reduced
49
Closed
26
Calls
$1.67M
Puts
$4.51M
Net Calls
-$2.85M
Net Calls Change
-$958K

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$14.5M
2
Goldman Sachs
Goldman Sachs
New York
+$8.7M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$6.51M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$6.48M
5
Renaissance Technologies
Renaissance Technologies
New York
+$5.75M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$8.97M
2
PAM
Panagora Asset Management
Massachusetts
-$4.75M
3
SFM
Sphera Funds Management
Israel
-$4.51M
4
Two Sigma Investments
Two Sigma Investments
New York
-$4.28M
5
SCM
Scopia Capital Management
New York
-$4.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Man Group
51
Man Group
United Kingdom
$817K -$54.7K -3,635 -6%
PPA
52
Parametric Portfolio Associates
Washington
$801K -$128K -8,526 -13%
PAI
53
Palo Alto Investors
California
$686K +$707K +47,000 New
Fisher Asset Management
54
Fisher Asset Management
Washington
$678K -$206K -13,700 -23%
AllianceBernstein
55
AllianceBernstein
Tennessee
$677K – – –
VEA
56
Virtus ETF Advisers
New York
$599K -$52.1K -3,465 -8%
PP
57
PDT Partners
New York
$570K +$588K +39,100 New
Barclays
58
Barclays
United Kingdom
$537K -$576K -38,305 -51%
CS
59
Credit Suisse
Switzerland
$523K -$89.9K -5,972 -14%
New York State Common Retirement Fund
60
New York State Common Retirement Fund
New York
$521K – – –
TI
61
Trexquant Investment
Connecticut
$520K +$167K +11,095 +45%
EAM
62
Erste Asset Management
Austria
$507K – – –
Citigroup
63
Citigroup
New York
$507K +$291K +19,327 +126%
WG
64
Winton Group
United Kingdom
$456K -$827K -54,934 -64%
Morgan Stanley
65
Morgan Stanley
New York
$453K -$790K -52,500 -63%
UBS AM
66
UBS AM
Illinois
$441K -$14.2K -943 -3%
AIM
67
Aigen Investment Management
New York
$438K -$214K -14,194 -32%
State Board of Administration of Florida Retirement System
68
State Board of Administration of Florida Retirement System
Florida
$399K – – –
Invesco
69
Invesco
Georgia
$389K +$141K +9,349 +54%
AIG
70
American International Group
New York
$358K -$21.3K -1,416 -5%
Susquehanna International Group
71
Susquehanna International Group
Pennsylvania
$358K +$369K +24,536 New
Wells Fargo
72
Wells Fargo
California
$333K -$566K -37,637 -62%
Acadian Asset Management
73
Acadian Asset Management
Massachusetts
$331K -$180K -11,945 -35%
DCM
74
Dupont Capital Management
Delaware
$310K +$320K +21,257 New
BNP Paribas Financial Markets
75
BNP Paribas Financial Markets
France
$307K +$244K +16,228 +336%
1 2
3
4 5

TVTX Hedge Fund Activity: Q1 2020 in Review

124 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Travere Therapeutics (TVTX) for Q1 2020, worth a combined $643M — up 5.2% from $611M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of TVTX and 20 opened new positions — a net loss of 6 holders — while 49 trimmed existing stakes and 32 added.

The largest buyer was Adage Capital Partners, adding an estimated $14.5M. The largest seller was Millennium Management, cutting an estimated $8.97M.

  • 124 institutional investors held Travere Therapeutics (TVTX) as of Q1 2020, down from 131 in Q4 2019.
  • Funds reported $643M of Travere Therapeutics stock for Q1 2020, up 5.2% quarter-over-quarter.
  • 20 funds opened new Travere Therapeutics positions in Q1 2020 and 26 closed out, a net change of -6 holders.
  • The largest Travere Therapeutics buyer in Q1 2020 was Adage Capital Partners, an estimated $14.5M added.
  • The largest Travere Therapeutics seller in Q1 2020 was Millennium Management, an estimated $8.97M sold.

Based on aggregated 13F filings for Q1 2020.